Human gene
LAMA3 laminin, alpha 3
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 1677 | Epidermolysis bullosa, junctionalis, LAMA3-related | dog | LAMA3 | one to one | Drug |
64.5
|
| 1677 | Epidermolysis bullosa, junctionalis, LAMA3-related | horse | LAMA3 | one to one | Drug |
64.5
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| laryngo-onycho-cutaneous syndrome | MONDO:0009513 | 0.77 | 225 |
| junctional epidermolysis bullosa Herlitz type | MONDO:0009182 | 0.72 | 345 |
| junctional epidermolysis bullosa, non-Herlitz type | MONDO:0009180 | 0.65 | 36 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Ocriplasmin | hydrolytic enzyme | Approved |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.